| Literature DB >> 28335336 |
Song-Hwa Bae1, Jin Yu2, Mi-Ran Go3, Hyun-Jin Kim4, Yun-Gu Hwang5, Soo-Jin Choi6.
Abstract
(1) Background: Application of nanotechnology or nanomaterials in agricultural food crops has attracted increasing attention with regard to improving crop production, quality, and nutrient utilization. Gold nanoparticles (Au-NPs) have been reported to enhance seed yield, germination rate, and anti-oxidant potential in food crops, raising concerns about their toxicity potential. In this study, we evaluated the oral toxicity of red ginseng exposed to colloidal Au-NPs during cultivation (G-red ginseng) in rats and their intestinal transport mechanism. (2)Entities:
Keywords: gold nanoparticle; oral toxicity; red ginseng; transport mechanism
Year: 2016 PMID: 28335336 PMCID: PMC5245760 DOI: 10.3390/nano6110208
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Saponin contents in Au-NP-treated ginseng or untreated ginseng controls.
| Type of Ginseng | Rg1 | Re | Rf | Rg2 | Rb1 | Rb3 | Rd | Total |
|---|---|---|---|---|---|---|---|---|
| Untreated ginseng | 1.67 | 1.43 | 0.33 | 0.13 | 2.48 | 0.18 | 0.12 | 6.34 |
| Au-NP-treated ginseng | 14.42 | 2.93 | 0.91 | 0.15 | 3.42 | 0.15 | 1.33 | 22.31 |
Concentration: mg/kg.
Figure 1Changes in (a) body weight gain; (b) food intake; and (c) water consumption in rats administered G-red ginseng extract, untreated red ginseng extract, or distilled water (DW) as a control.
Organo-somatic indices of rats after 14-day repeated oral administration of G-red ginseng extract or untreated red ginseng extract.
| Organ | Control | Untreated Red Ginseng Extract | G-red Ginseng Extract |
|---|---|---|---|
| Brain | 0.92 ± 0.07 | 1.03 ± 0.13 | 0.91 ± 0.11 |
| Heart | 0.38 ± 0.04 | 0.37 ± 0.04 | 0.37 ± 0.04 |
| Kidney | 0.97 ± 0.08 | 1.01 ± 0.11 | 0.89 ± 0.10 |
| Large Intestine | 1.49 ± 0.26 | 1.51 ± 0.35 | 1.24 ± 0.29 |
| Liver | 4.41 ± 0.20 | 4.93 ± 0.56 | 4.12 ± 0.45 |
| Lung | 0.52 ± 0.04 | 0.47 ± 0.18 | 0.55 ± 0.10 |
| Ovary | 0.04 ± 0.01 | 0.07 ± 0.01 | 0.05 ± 0.01 |
| Small Intestine | 4.27 ± 0.42 | 4.62 ± 0.04 | 3.81 ± 0.32 |
| Spleen | 0.28 ± 0.02 | 0.35 ± 0.01 | 0.28 ± 0.04 |
| Stomach | 2.23 ± 0.63 | 1.60 ± 0.10 | 1.82 ± 0.30 |
All data showed no statistical differences from the control (DW) groups (p > 0.05).
Hematological and coagulation time values in rats after 14-day repeated oral administration of G-red ginseng extract or untreated red ginseng extract.
| Test Groups | WBC | WBC Differential Counting (%) | RBC | Hb | HCT | MCV | MCH | MCHC | RETI | PLT | PT | APTT | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (103/μL) | NE | LY | MO | EO | BA | (106/μL) | (g/dL) | (%) | (fL) | (pg) | (g/dL) | (%) | (103/μL) | (s) | (s) | |
| 5.4 ± 3.2 | 12.2 ± 6.9 | 82.2 ± 7.6 | 1.7 ± 0.3 | 1.8 ± 1.3 | 0.7 ± 0.4 | 6.5 ± 1.9 | 12.8 ± 3.4 | 40.3 ± 11.0 | 62.4 ± 1.6 | 20.0 ± 0.7 | 32.0 ± 0.5 | 3.0 ± 0.2 | 515 ± 571 | 14.0 ± 0.9 | 41.7 ± 4.4 | |
| 7.8 ± 1.5 | 7.2 ± 1.6 | 87.4 ± 2.2 | 2.1 ± 0.5 | 1.3 ± 0.2 | 0.7 ± 0.3 | 7.7 ± 0.3 | 15.3 ± 0.5 | 47.8 ± 1.4 | 62.5 ± 1.1 | 19.9 ± 0.3 | 31.9 ± 0.2 | 2.4 ± 0.4 | 1104 ± 305 | 13.3 ± 0.5 | 36 ± 8.3 | |
| 6.0 ± 0.9 | 5.8 ± 1.2 | 88.0 ± 1.4 | 2.1 ± 0.6 | 1.5 ± 0.4 | 0.5 ± 0.3 | 7.1 ± 0.4 | 13.7 ± 0.8 | 47.4 ± 2.6 | 67.1 ± 1.5 | 19.4 ± 0.5 | 28.9 ± 0.2 | 2.2 ± 0.3 | 921 ± 44 | 13.2 ± 0.6 | 23.2 ± 1.9 | |
| 6.6 ± 1.2 | 7.1 ± 3.5 | 86.6 ± 3.6 | 2.2 ± 0.5 | 1.8 ± 0.4 | 0.6 ± 0.1 | 7.6 ± 0.5 | 14.4 ± 0.8 | 49.4 ± 2.6 | 65.1 ± 1.3 | 19.0 ± 0.4 | 29.2 ± 0.3 | 2.19 ± 0.33 | 890 ± 173 | 14.1 ± 0.9 | 27.4 ± 6.9 | |
Abbreviation: WBC, total leucocyte count; NE, neutrophils; LY, lymphocytes; MO, monocytes; EO, eosinophils; BA, basophils; RBC, total erythrocyte count; Hb, hemoglobin concentration; HCT, hematocrit; MCV, mean cell volume; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; RETI, reticulocyte; PLT, platelet; PT, prothrombin time; APTT, activated partial thromboplastin time. Statistical analysis of untreated red ginseng extract and G-red ginseng extract were performed compared to control 1 and control 2, respectively. Data were expressed as means ± standard deviations. All treated groups showed no significant differences from the control 1 or control 2 (distilled water) group (p > 0.05).
Serum biochemical values in rats after 14-day repeated oral administration of G-red ginseng extract or untreated red ginseng extract.
| Test Groups | TP | ALB | A/G | T-BIL | ALP | AST | ALT | CREA | BUN | CHOL | TG | GLU | CA | IP | CK | Na | K | Cl |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (g/dL) | (g/dL) | - | (mg/dL) | (U/L) | (U/L) | (U/L) | (mg/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (IU/L) | (mmol/L) | (mmol/L) | (mmol/L) | |
| 6.9 ± 0.2 | 4.3 ± 0.2 | 1.7 ± 0.1 | 0.0 ± 0.0 | 851 ± 218 | 85 ± 4 | 34 ± 5 | 0.5 ± 0.1 | 20.9 ± 2.1 | 96 ± 7 | 113 ± 16 | 366 ± 105 | 12.2 ± 0.8 | 9.6 ± 0.7 | 178 ± 49 | 145.6 ± 1.6 | 6.6 ± 0.7 | 99.7 ± 1.8 | |
| 8.8 ± 0.0 | 5.0 ± 0.1 | 1.4 ± 0.1 | 0.0 ± 0.0 | 864 ± 115 | 174 ± 21 | 46 ± 11 | 0.5 ± 0.1 | 22.6 ± 2.3 | 93 ± 14 | 106 ± 12 | 461 ± 277 | 12.9 ± 1.0 | 11.8 ± 1.3 | 1735 ± 230 | 141.5 ± 0.8 | 11.0 ± 0.5 | 101.6 ± 2.5 | |
| 6.5 ± 0.2 | 4.3±0.1 | 2.0 ± 0.0 | 0.0 ± 0.0 | 1116 ± 117 | 76 ± 7 | 37 ± 5 | 0.5 ± 0.1 | 21.4 ± 3.2 | 83 ± 6 | 90 ± 19 | 286 ± 51 | 13.1 ± 0.2 | 9.8 ± 0.7 | 112 ± 10 | 147.5 ± 1.0 | 5.5 ± 0.5 | 97.1 ± 1.2 | |
| 6.7 ± 0.2 | 4.5±0.1 | 2.0 ± 0.1 | 0.0 ± 0.0 | 904 ± 148 | 77 ± 7 | 26 ± 4 | 0.5 ± 0.1 | 21.4 ± 2.0 | 86 ± 8 | 52 ± 28 | 268 ± 43 | 12.8 ± 0.5 | 9.1 ± 0.9 | 113 ± 18 | 148.4 ± 1.5 | 5.4 ± 0.6 | 98.2 ± 2.7 |
Abbreviation: TP, total protein; ALB, albumin; A/G, A/G ratio; T-BIL, total bilirubin; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CREA, creatinine; BUN, blood urea nitrogen; CHOL, total cholesterol; TG, triglycerides; GLU, glucose; CA, calcium; IP, inorganic phosphorus; CK, creatine kinase; Na, sodium; K, potassium; Cl, chloride. Statistical analysis of untreated red ginseng extract and G-red ginseng extract were performed compared to control 1 and control 2, respectively. Data were expressed as means ± standard deviations. All treated groups showed no significant differences from the control 1 or control 2 (DW) group (p > 0.05).
Figure 2Normal histopathological sections of kidneys, liver, lungs and spleen in the control (DW) and G-red ginseng extract-treated rats after 14-day repeated oral administration. Images are magnified at 50×.
Figure 3(a) Intestinal transport of Au-NPs or Au3+ ions using an in vitro follicle-associated epithelium (FAE) model and Caco-2 monolayers; (b) Transport amounts of Au-NPs or Au3+ ions at different temperatures (37 °C and 4 °C), after pre-treatment with a clathrin-mediated endocytosis inhibitor, chlorpromazine, and after ethylene glycol tetraacetic acid (EGTA) treatment. a−c Different letters in bars indicate significant differences among control (medium), Au-NP-, and Au3+ ion-treated groups (p < 0.05). A,B Different letters in bars indicate significant difference in uptake amounts at 37 °C and 4 °C, with/without inhibitor treatment, and with/without EGTA treatment (p < 0.05).